cutepress: AI Cartoon Avatar

Description

CardioRisk Calculator™ simplifies cardiovascular risk stratification and is a Canadian dyslipidemia guidelines application.

CardioRisk Calculator™ provides:
-quick calculations on % LDL-C reductions
-concise drug dosage information
-clear snapshot of a patient's CV risk
-options to bring lipid levels to target
-easy identification of familial hypercholesterolemia
This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia.
Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order):
- Amgen Canada
- Bayer Inc
- Boehringer Ingelheim (Canada) Ltd
- FH Canada
- HLS Therapeutics
- Janssen Inc
- Novo Nordisk Canada
- Sanofi Canada
Hide Show More...

Screenshots

Cutepress FAQ

  • Is Cutepress free?

    Yes, Cutepress is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Cutepress legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Cutepress cost?

    Cutepress is free.

  • What is Cutepress revenue?

    To get estimated revenue of Cutepress app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Russia yet.
Ratings History

Cutepress Reviews

No Reviews in Russia
App doesn't have any reviews in Russia yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Cutepress Competitors

CardioRisk Calculator Installs

Last 30 days

CardioRisk Calculator Revenue

Last 30 days

Cutepress Revenue and Downloads

Gain valuable insights into CardioRisk Calculator performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.